[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. The company's lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Paul  Rodrique", "title": "Senior VP & Global Head of Quality Assurance", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary  Bostanxhi M.B.A.", "title": "VP of Finance & Controller", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.71, "open": 14.84, "dayLow": 14.48, "dayHigh": 15.61, "regularMarketPreviousClose": 14.71, "regularMarketOpen": 14.84, "regularMarketDayLow": 14.48, "regularMarketDayHigh": 15.61, "payoutRatio": 0.0, "forwardPE": -9.006211, "volume": 726231, "regularMarketVolume": 725849, "averageVolume": 509858, "averageVolume10days": 608110, "averageDailyVolume10Day": 608110, "bid": 14.4, "ask": 14.69, "bidSize": 1, "askSize": 1, "marketCap": 790774912, "fiftyTwoWeekLow": 8.91, "fiftyTwoWeekHigh": 28.09, "fiftyDayAverage": 13.0746, "twoHundredDayAverage": 17.140598, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 301615232, "profitMargins": 0.0, "floatShares": 28372303, "sharesOutstanding": 54536200, "sharesShort": 5391114, "sharesShortPriorMonth": 5046885, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.098900005, "heldPercentInsiders": 0.00434, "heldPercentInstitutions": 0.85933995, "shortRatio": 8.91, "impliedSharesOutstanding": 54536200, "bookValue": 9.035, "priceToBook": 1.60487, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -67995000, "trailingEps": -4.05, "forwardEps": -1.61, "enterpriseToEbitda": -3.663, "52WeekChange": -0.3806066, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 14.5, "targetHighPrice": 48.0, "targetLowPrice": 8.0, "targetMeanPrice": 33.2, "targetMedianPrice": 36.0, "recommendationMean": 1.85714, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 489711008, "totalCashPerShare": 8.982, "ebitda": -82333000, "totalDebt": 738000, "quickRatio": 27.221, "currentRatio": 27.934, "debtToEquity": 0.15, "returnOnAssets": -0.13843, "returnOnEquity": -0.19143, "freeCashflow": -53717124, "operatingCashflow": -74751000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.4276005, "regularMarketPrice": 14.5, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1746216309, "regularMarketTime": 1746216001, "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 14.5, "postMarketChange": 0.0, "regularMarketChange": -0.21000004, "regularMarketDayRange": "14.48 - 15.61", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 509858, "fiftyTwoWeekLowChange": 5.59, "fiftyTwoWeekLowChangePercent": 0.62738496, "fiftyTwoWeekRange": "8.91 - 28.09", "fiftyTwoWeekHighChange": -13.59, "fiftyTwoWeekHighChangePercent": -0.48380208, "fiftyTwoWeekChangePercent": -38.060658, "earningsTimestamp": 1743075049, "earningsTimestampStart": 1743075049, "earningsTimestampEnd": 1743075049, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.05, "epsForward": -1.61, "epsCurrentYear": -1.642, "priceEpsCurrentYear": -8.830694, "fiftyDayAverageChange": 1.4253998, "fiftyDayAverageChangePercent": 0.109020524, "twoHundredDayAverageChange": -2.6405983, "twoHundredDayAverageChangePercent": -0.1540552, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]